PROVIDER PROFILE · NPI 1659464550
Charles SoparkarM.D., PH.D
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
803
Unique beneficiaries
—
Total services
10,916
Distinct HCPCS
18
Medicare payment
$357K
Peer benchmark
Total Medicare services vs. 1,238 Ophthalmology providers in TX — top quintile (cohort median 1,864).
PRESCRIBING · PART D · 2024
Total Rx claims
953
Beneficiaries
—
Total drug cost
$6K
Distinct drugs
9
Brand share
36.2%
Top prescribed drugs
Erythromycin Base209 claims
Cephalexin193 claims
Doxycycline Monohydrate125 claims
Neomycin/Polymyxin B/Dexametha109 claims
Diazepam98 claims
QUALITY · MIPS · 2024
Final MIPS score
75.0
Quality
0.0
Cost
0.0
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
0.00%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$820
Payment records
14
By payment type
Food and Beverage$820
Top paying entities
Food and Beverage$820
REFERRAL NETWORK
Where Charles Soparkar's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Houston, TX | 35 | 80 |
| UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER | 14 | 41 |
| Clinical Pathology Laboratories, Inc. Clinical Laboratory · Austin, TX | 13 | 33 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE